RCEL

#3760
Avita Medical, Inc. Common Stock
5.60 USD
+14.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
5.60
5.60
Rango anual
3.22
10.29
Cambio diario
+14.05%
Variación mensual
+21.21%
Variación en los últimos 6 meses
+6.87%
Cambio anual
-35.33%
Cierres anteriores
4.91
Abrir
5.60
Bid
Ask
Mínimo
5.60
High
5.60
Volumen
22
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 171.54 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.98
Relación precio/flujo de caja
1.34

Avita Medical Inc

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

Noticias